We continue to develop pure and stable cultures of primary human cells derived from our commercially available UCB derived mesenchymal stem cells, including cardiomyocytes; which expand in our cardiomyoctye maintaining medium (PC00B6) and have the ability to grow in low oxygen.
Neuromics also offers primary rat and mouse cardiomyocyte tissue and disassociated cells, in addition to our human derived cardiomyocytes.
These cells are optimized to provide addition options for in-vitro testing of drug to drug candidate toxicities allowing researchers to rule out the ineffective and potentially small compounds/toxic compounds early in the process.